Rinsulin NPH + Humulin NPH
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
15
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacokinetics
Conditions
Pharmacokinetics, Bioequivalence
Trial Timeline
Oct 23, 2017 → May 21, 2018
NCT ID
NCT04501250About Rinsulin NPH + Humulin NPH
Rinsulin NPH + Humulin NPH is a pre-clinical stage product being developed by GEROPHARM for Pharmacokinetics. The current trial status is completed. This product is registered under clinical trial identifier NCT04501250. Target conditions include Pharmacokinetics, Bioequivalence.
Hype Score Breakdown
Clinical
5
Activity
2
Company
2
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04501250 | Pre-clinical | Completed |
Competing Products
20 competing products in Pharmacokinetics